When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HGEN - Humanigen up 156% on planned study of lenzilumab in Covid-19
Humanigen Inc.
Ultra-thinly traded micro cap Humanigen (OTCQB:HGEN+156%) rockets up on a 16x surge in volume, a scant 67K shares, in response to its proposed plan to conduct a Phase 3 clinical trial evaluating lead drug lenzilumab for the prevention and treatment of cytokine storm (potentially life-threatening out-of-control immune response) that could lead to acute respiratory distress syndrome associated with SARS-CoV-2 infection, the coronavirus responsible for the COVID-19 outbreak.
More news on: Humanigen, Inc., Healthcare stocks news, Stocks on the move,